000756 新华制药
交易中 08-14 10:56:15
资讯
新帖
简况
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
证券之星 · 08-10
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
新华制药（000756）披露2025年度A股派息实施公告，7月22日股价上涨0.07%
证券之星 · 07-22
新华制药（000756）披露2025年度A股派息实施公告，7月22日股价上涨0.07%
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
证券之星 · 07-08
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
6月29日新华制药（000756）涨停分析：新药获批、一致性评价驱动
证券之星 · 06-29
6月29日新华制药（000756）涨停分析：新药获批、一致性评价驱动
异动快报：新华制药（000756）6月29日10点9分触及涨停板
证券之星 · 06-29
异动快报：新华制药（000756）6月29日10点9分触及涨停板
新华制药（000756）披露2025年周年股东会决议公告，6月26日股价下跌8.18%
证券之星 · 06-26
新华制药（000756）披露2025年周年股东会决议公告，6月26日股价下跌8.18%
股市必读：新华制药6月23日涨停收盘，收盘价13.44元
证券之星 · 06-24
股市必读：新华制药6月23日涨停收盘，收盘价13.44元
亚太市场遭遇“黑色星期二” 恒科跌超3%，MiniMax跌超16%，超百亿港元资金抄底！
每日经济新闻 · 06-23
亚太市场遭遇“黑色星期二” 恒科跌超3%，MiniMax跌超16%，超百亿港元资金抄底！
创新药板块盘初冲高，海南海药、新华制药涨停
每日经济新闻 · 06-23
创新药板块盘初冲高，海南海药、新华制药涨停
新华制药：LXH-2103注射液获临床试验批准
南方财经网 · 06-22
新华制药：LXH-2103注射液获临床试验批准
新华制药：公司始终心无旁骛做好主业
证券之星 · 06-10
新华制药：公司始终心无旁骛做好主业
新华制药（000756）披露获得碳酸司维拉姆干混悬剂药品注册证书公告，6月2日股价下跌0.88%
证券之星 · 06-02
新华制药（000756）披露获得碳酸司维拉姆干混悬剂药品注册证书公告，6月2日股价下跌0.88%
港股公告掘金 | 智谱拟发行A股并在科创板上市
智通财经 · 06-02
港股公告掘金 | 智谱拟发行A股并在科创板上市
新华制药：获批“碳酸司维拉姆干混悬剂”药品注册证书
财中社 · 06-01
新华制药：获批“碳酸司维拉姆干混悬剂”药品注册证书
新华制药（000756）披露2025年度周年股东会通知，5月26日股价下跌1.8%
证券之星 · 05-26
新华制药（000756）披露2025年度周年股东会通知，5月26日股价下跌1.8%
新华制药(000756.SZ)：苯巴比妥片通过仿制药一致性评价
智通财经 · 05-18
新华制药(000756.SZ)：苯巴比妥片通过仿制药一致性评价
股市必读：新华制药（000756）5月15日披露最新机构调研信息
证券之星 · 05-18
股市必读：新华制药（000756）5月15日披露最新机构调研信息
新华制药（000756）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.68%
证券之星 · 05-13
新华制药（000756）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.68%
新华制药：公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品
证券之星 · 05-13
新华制药：公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品
新华制药：氨溴特罗口服溶液获得药品注册证书
南方财经网 · 05-11
新华制药：氨溴特罗口服溶液获得药品注册证书
加载更多
公司概况
公司名称：
山东新华制药股份有限公司
所属行业：
医药制造业
上市日期：
1997-08-06
主营业务：
山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是解热镇痛类等原料药、片剂、针剂、胶囊剂等制剂、医药中间体及其他。
发行价格：
3.45
{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":14.19,"timestamp":1786676175000,"preClose":14.03,"halted":0,"volume":11758196,"delay":0,"changeRate":0.0114,"floatShares":499000000,"shares":697000000,"eps":0.3757,"marketStatus":"交易中","change":0.16,"latestTime":"08-14 10:56:15","open":14,"high":14.49,"low":13.78,"amount":167000000,"amplitude":0.0506,"askPrice":14.19,"askSize":458,"bidPrice":14.18,"bidSize":160,"shortable":0,"etf":0,"ttmEps":0.3757,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786678200000},"marketStatusCode":2,"adr":0,"adjPreClose":14.03,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":15.43,"lowLimit":12.63,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":696683435,"isCdr":false,"pbRate":1.83,"roa":"--","peRate":37.769497,"roe":"1.59%","epsLYR":0.42,"committee":0.014907,"marketValue":9886000000,"turnoverRate":0.0236,"status":0,"hkstockBrief":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":6.015,"timestamp":1786676056258,"preClose":6.015,"halted":0,"volume":345200,"delay":0,"premium":"-63.56"},"floatMarketCap":7079000000},"requestUrl":"/m/hq/s/000756","defaultTab":"news","newsList":[{"id":"2658989062","title":"新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989062","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658989062?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:42","pubTimestamp":1786351326,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药08月10日在投资者关系平台上答复投资者关心的问题。公司于2025年 6月20 日在巨潮资讯网公告了《关于 OAB-14 干混悬剂完成Ⅱ期临床中国首例患者入组的公告》，Ⅱ期临床试验正按计划推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000020678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653676526","title":"新华制药（000756）披露2025年度A股派息实施公告，7月22日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653676526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653676526?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:12","pubTimestamp":1784729540,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，新华制药报收于13.48元，较前一交易日上涨0.07%，最新总市值为93.91亿元。近日，新华制药发布2025年度A股派息实施公告。公告显示，公司2025年度A股派息方案已获2026年6月26日召开的年度股东会审议通过，以现有A股股本501,683,435股为基数，向全体A股股东每10股派发现金红利1.50元（含税）。H股股东权益分派不适用本公告。本次派息方案实施后，公司将按规定调整股票期权激励计划行权价格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159982","399300","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649682956","title":"新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2649682956","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649682956?lang=zh_cn&edition=full","pubTime":"2026-07-08 08:39","pubTimestamp":1783471153,"startTime":"0","endTime":"0","summary":"投资者提问：董秘你好，贵公司新华制药的阿尔茨海默病新药OAB-14已进入I期临床试验，受试者入组基本完成，具备清除AB淀粉样蛋白等多靶点特性，是当前全球首个靶向AB清除的多靶点小分子抗AD药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800008255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647632941","title":"6月29日新华制药（000756）涨停分析：新药获批、一致性评价驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2647632941","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647632941?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:33","pubTimestamp":1782718432,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药6月29日涨停收盘，收盘价13.59元。6月29日新华制药涨停的可能因素有：公司于6月27日公告获批盐酸莫西沙星氯化钠注射液药品注册证书，属抗感染领域重磅仿制药；同期披露布洛芬混悬液通过一致性评价，强化OTC与处方药双线布局；叠加近期医药板块政策面回暖，国家医保谈判节奏预期调整及集采温和化信号增强，市场对公司存量品种放量及新批文落地预期提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647342499","title":"异动快报：新华制药（000756）6月29日10点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647342499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647342499?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:10","pubTimestamp":1782699051,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，10点9分新华制药（000756）触及涨停板。其所属行业化学制药目前上涨。领涨股为广生堂。该股为阿尔茨海默病，创新药，合成生物概念热股，当日阿尔茨海默病概念上涨2.38%，创新药概念上涨1.88%，合成生物概念上涨1.66%。6月26日的资金流向数据方面，主力资金净流出1940.84万元，占总成交额5.8%，游资资金净流出269.93万元，占总成交额0.81%，散户资金净流入2210.77万元，占总成交额6.6%。近5日资金流向一览见下表：新华制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900007610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365872","title":"新华制药（000756）披露2025年周年股东会决议公告，6月26日股价下跌8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646365872?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:27","pubTimestamp":1782484040,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，新华制药报收于12.35元，较前一交易日下跌8.18%，最新总市值为86.04亿元。该股当日开盘13.35元，最高13.76元，最低12.35元，成交额达3.35亿元，换手率为5.19%。近日，山东新华制药股份有限公司发布2025年周年股东会决议公告。会议还审议通过了续聘致同会计师事务所为2026年度审计机构、2026年度董事薪酬方案及董事高管薪酬管理制度等议案。现场及网络投票股东共336人，代表有表决权股份总数33.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645858028","title":"股市必读：新华制药6月23日涨停收盘，收盘价13.44元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645858028","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645858028?lang=zh_cn&edition=full","pubTime":"2026-06-24 00:57","pubTimestamp":1782233832,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，新华制药报收于13.44元，上涨9.98%，涨停，换手率2.13%，成交量10.61万手，成交额1.41亿元。交易信息汇总股价提醒新华制药6月23日涨停收盘，收盘价13.44元；该股于9点32分涨停，盘中1次打开涨停；截至收盘，封单资金为7412.49万元，占其流通市值1.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400000872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645431882","title":"亚太市场遭遇“黑色星期二” 恒科跌超3%，MiniMax跌超16%，超百亿港元资金抄底！","url":"https://stock-news.laohu8.com/highlight/detail?id=2645431882","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645431882?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:36","pubTimestamp":1782207374,"startTime":"0","endTime":"0","summary":"今日（6月23日），亚太市场遭遇“黑色星期二”，各市场主要股指全线下挫，港股市场自然难以独善其身。截至收盘，恒生指数报23336.28点，下跌432.24点，跌幅1.82%。恒生科技指数报4399.22点，下跌150.19点，跌幅3.30%。周边市场方面，日经225指数大跌3.55%，韩国KOSPI指数跌近10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779798183.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779798183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02837","03033","09067","BK0229","02833","MHImain","03037","07552","82800","83115","HHImain","BK0155","513600","06067","03419","07226","000756","BK1191","MCHmain","03088","00719","07300","03067","09088","300568","BK1515","07200","09115","03115","03032","HSI","07500","BK0201","HSTECH","02800","03423","03417"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645300158","title":"创新药板块盘初冲高，海南海药、新华制药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2645300158","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645300158?lang=zh_cn&edition=full","pubTime":"2026-06-23 09:36","pubTimestamp":1782178606,"startTime":"0","endTime":"0","summary":"6月23日，创新药板块盘初冲高，海南海药、新华制药涨停，粤万年青、华森制药、长春高新、小方制药、通化东宝跟涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779039790.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779039790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0146","BK0188","159992","BK0164","000756","BK0060","BK0070","000566","06978","BK0239","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645028951","title":"新华制药：LXH-2103注射液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2645028951","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645028951?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:08","pubTimestamp":1782119284,"startTime":"0","endTime":"0","summary":"南财智讯6月22日电，新华制药公告，LXH-2103注射液收到国家药品监督管理局签发的《药物临床试验批准通知书》（通知书编号：2026LP01818），同意开展术后中至重度疼痛的临床试验。该药品为化学药品1类创新药，剂型为注射液，规格为1ml：50mg，拟用于术后中至重度疼痛治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606223778097584.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606223778097584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642645416","title":"新华制药：公司始终心无旁骛做好主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2642645416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642645416?lang=zh_cn&edition=full","pubTime":"2026-06-10 08:54","pubTimestamp":1781052850,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药(000756)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，自从2025年6月份到今年六月份大盘上涨这一千多点，新华制药股价没有任何表现，近期股价从17元跌倒了12元左右，作为一家优质上市药企，近期是否有增持或者回购股票的意向，或者有什么计划加强投资者的信心，回报股东提升股价？新华制药回复：您好！股价变化会受多重因素影响，如市场竞争、行业政策与周期、公司基本面、市场情绪与预期、资金流动等。公司始终心无旁骛做好主业，努力提升业绩，争取为投资者创造更大价值。感谢您对公司关心与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000007739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914631","title":"新华制药（000756）披露获得碳酸司维拉姆干混悬剂药品注册证书公告，6月2日股价下跌0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640914631?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:05","pubTimestamp":1780394735,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，新华制药报收于13.45元，较前一交易日下跌0.88%，最新总市值为93.7亿元。新华制药于近日披露《关于获得碳酸司维拉姆干混悬剂药品注册证书的公告》。公告显示，公司近日收到国家药品监督管理局核准签发的碳酸司维拉姆干混悬剂《药品注册证书》，药品注册分类为化学药品3类，规格为0.8g和2.4g，申请事项为境内生产药品注册。2025年中国公立医疗机构司维拉姆相关制剂销售额约为7.5亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200035714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995865","title":"港股公告掘金 | 智谱拟发行A股并在科创板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995865","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640995865?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:00","pubTimestamp":1780362051,"startTime":"0","endTime":"0","summary":"重大事项：丽珠医药：重组人促卵泡激素注射液获得《药品注册证书》山东新华制药股份：获得碳酸司维拉姆干混悬剂药品注册证书白云山：白云山制药总厂收到国家药监局核准签发的关于磷酸奥司他韦干混悬剂的《药品注册证书》智谱拟发行A股并在科创板上市驭势科技：与赛力斯凤凰智创完成行泊一体乘用车海外量产及交付澜起科技：横琴公司拟进行增资扩股并引入新投资方 引资合共约5亿元股东持续赋能!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0327786744.USD","LU0289960550.SGD","LU0370786039.SGD","LU0540923850.HKD","LU0856984785.SGD","LU0164865239.USD","LU0173614495.USD","LU1770034418.SGD","IE00BZ08YS42.EUR","LU1282651121.HKD","LU0320764243.SGD","02886","LU0633140560.USD","LU0501845795.SGD","BK1521","LU0051755006.USD","LU1064131003.USD","LU1688375341.USD","LU2097828805.USD","LU0979878070.USD","LU0577902538.SGD","LU0561508036.HKD","LU2294711713.HKD","IE0034224299.USD","LU0708995583.HKD","LU0868486357.SGD","LU0502904849.HKD","LU0307460666.USD","09866","LU0348825331.USD","LU0737861699.HKD","LU0819121731.USD","LU0650527681.SGD","LU0700851271.USD","LU1734074674.USD","LU0293314216.USD","LU1880383440.USD","LU2488822045.USD","LU0359202008.SGD","LU2449936058.SGD","LU1282648689.USD","LU2226246903.HKD","LU1675838814.USD","LU1152091168.USD","09868","LU0531971595.HKD","LU2097828557.USD","LU0516422952.EUR","SG9999000459.SGD","LU0823038988.USD","LU0143863198.USD","IE00B29SXG58.USD","BK1515","LU0456846285.SGD","BK1221","LU0828237510.HKD","BK1610","LU0823039010.USD","LU0259732245.USD","LU0605514214.HKD","LU0054450605.USD","LU0067412154.USD","LU2125910500.SGD","LU0181495838.USD","LU2257852520.SGD","IE00B3M56506.USD","LU1102505929.USD","LU0873338254.USD","LU0072913022.USD","07489","LU0289739343.SGD","LU0823040885.USD","00175","LU0229945570.USD","LU1105468828.SGD","SG9999001226.SGD","LU0254981946.USD","LU1188198961.HKD","LU1008478684.HKD","LU0231483743.USD","LU1813983027.USD","LU0593848301.USD","LU0431992006.USD","LU0589944569.HKD","LU0128522157.USD","LU0449509016.USD","81211","LU0463099449.HKD","BK1615","BK1163","LU0823426480.USD","BK1591","LU1961090484.USD","LU1102505762.USD","BK1575","LU0572944931.SGD","LU0320764755.SGD","LU0878005551.USD","LU0315178854.USD","LU0345775950.USD","LU1880383366.USD","LU2348774022.SGD","LU0511384066.AUD","LU0449515922.USD","LU1282651048.USD","03690","LU0214875030.USD","SG9999014674.SGD","LU0165289439.USD","LU0672654166.SGD","IE0008368742.USD","688008","LU1152091754.HKD","LU1861219969.SGD","601127","LU0577902371.SGD","LU0128522744.USD","LU0456827905.SGD","LU1303224171.USD","LU0289961442.SGD","BK1618","LU0048597586.USD","LU0577902298.EUR","LU2039709279.SGD","LU0588545904.SGD","GELYY","IE00BD6J9T35.USD","LU0039217434.USD","LU0708995153.HKD","LU1048588211.SGD","LU0140636845.USD","LU2097828714.EUR","LU1226287529.USD","IE00BZ08YR35.GBP","SG9999002463.SGD","IE0008369823.USD","IE0032431581.USD","LU0541501648.USD","LU0577902454.USD","LU0531970944.HKD","BK1197","LU1064130708.USD","BK1233","LU0132412106.USD","LU0417516738.SGD","BK1583","LU2357125470.USD","LU0819123356.HKD","LU0011963245.USD","LU0543330483.HKD","LU0228659784.USD","LU2242644610.SGD","XPEV","LU1048596156.SGD","LU0315179316.USD","SG9999015986.USD","LU0211977185.USD","LU0588545730.USD","LU0196878994.USD","LU1861214812.USD","HYDD.SI","LU0117841782.USD","LU0577902611.USD","SG9999006597.SGD","LU0541502299.USD","82333","LU1328615791.USD","LU0164880469.USD","LU0043850808.USD","LU0314109678.HKD","LU2152927971.USD","LU0455707207.USD","LU2148510915.USD","LU1224709979.USD","00874","LU0588546209.SGD","BK1117","BK1588","LU0505663152.USD","LU0918141705.HKD","LU1242518857.USD","LU0359201612.USD","LU0251144936.SGD","BK1604","000513","LU0516422440.USD","LU0880133367.SGD","BK1509","SG9999015978.USD","BK1522","LU2476274308.USD","LU1794554557.SGD","LU0052750758.USD","LU2153592121.USD","LU1224444064.USD","LU0634319403.HKD","LU0611395673.USD","BK1539","LU0048580855.USD","LU0516423091.SGD","IE00BF5LJ272.USD","SG9999002828.SGD","BK1191","LU2087589342.USD","LU1770036033.HKD","000756","SG9999002562.SGD","LU0345776255.USD","LU0821914370.USD","LU0348805143.USD","LU2045819591.USD","LU1831875114.USD","LU0594300419.USD","LU2399975544.HKD","LU0516422366.SGD","01511","METmain","LU0049853897.USD","00719","LU0823041008.USD","LU0509642566.USD","LU0828238088.HKD","LU0149721374.USD","02513","LU0175139822.USD","LU0320764599.SGD","LU0348816934.USD","LU0918141887.USD","IE00BZ08YT58.USD","LU1251922891.USD","002594","LU1993786604.SGD","LU0348735423.USD","LU2097828474.EUR","BK1587","LU1323998911.USD","HMTD.SI","LU0543330566.HKD","LU0348788117.USD","LU1807302812.USD","LU0106252389.USD","LU0516423174.USD","LU0164872284.USD","01513","601633","BK1540","LU0348814723.USD","SG9999015945.SGD","LU0828237940.HKD","09973","LU2097828631.EUR","LU0029874905.USD","NIO","GWLLY","LU0871576103.HKD","LU2249611893.SGD","SG9999001689.USD","06809","BYDDY","02333","LU0823414478.USD","LU0269904917.USD","09927","IE00B031HY20.USD","SG9999006514.SGD","NIO.SI","LU1868837565.USD","LU0326948709.USD","LU0683595622.HKD","LU0588545490.SGD","LU0210526637.USD","LU0244354667.USD","IE00B5MMRT66.SGD","LU0499858438.USD","LU0594300179.USD","LU0287142896.SGD","IE00B543WZ88.USD","SG9999001903.USD","MPNGY","BK1142","LU1023057109.AUD","IE00B0JY6N72.USD","LU1719994722.HKD","LU0047713382.USD","LU2506951792.HKD","600332","LU0469268626.HKD","01211","LU2476274720.SGD","LU1481107354.HKD","BK1582","LU0348827113.USD","LU2778985437.USD","LU0054237671.USD","LU0499858602.USD","LU0143863784.USD","LU1868837722.USD","LU0261950983.USD","LU0797268264.HKD","LU0084288322.USD","LU0029875118.USD","LU1720050803.USD","LU1242518931.SGD","LU0823414551.USD","SG9999015952.SGD","LU0417516902.SGD","LU0865486749.SGD","LU1960683339.HKD","LU1868838027.USD","BK1594","80175","LU1328277881.USD","IE00BPRC5H50.USD","LU2360107325.USD","BK1119","LU0359201885.HKD","LU1808992512.USD","LU0633140727.USD","BK1589","LU0072462343.USD","BK1606","SG9999000327.SGD","LU0823426308.USD","LU0326950275.SGD","EVS.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640627937","title":"新华制药：获批“碳酸司维拉姆干混悬剂”药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640627937","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640627937?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:08","pubTimestamp":1780304880,"startTime":"0","endTime":"0","summary":"6月1日，新华制药（000756/00719）发布公告，近日获得国家药品监督管理局核准签发的碳酸司维拉姆干混悬剂《药品注册证书》。该药品为处方药，规格为0.8g和2.4g，注册分类为化学药品3类。该药品主要用于控制正在接受透析治疗的慢性肾脏病成人患者的高磷血症，以及未进行透析的慢性肾脏病成人患者的高磷血症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606013756095150.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606013756095150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638554335","title":"新华制药（000756）披露2025年度周年股东会通知，5月26日股价下跌1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638554335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638554335?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:24","pubTimestamp":1779805465,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，新华制药报收于13.66元，较前一交易日下跌1.8%，最新总市值为95.17亿元。该股当日开盘13.93元，最高13.97元，最低13.57元，成交额达7249.83万元，换手率为1.06%。近日，山东新华制药股份有限公司披露《关于召开2025年度周年股东会的通知》。公告显示，公司将于2026年6月26日召开2025年度周年股东会，现场会议地点为山东省淄博市高新区鲁泰大道1号公司会议室。网络投票通过深圳证券交易所系统进行，股权登记日为2026年6月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636263730","title":"新华制药(000756.SZ)：苯巴比妥片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2636263730","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636263730?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:56","pubTimestamp":1779094607,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 新华制药(000756.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的苯巴比妥片(以下简称“本品”)《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。本品主要用于治疗焦虑、失眠(用于睡眠时间短早醒患者)、癫痫，是治疗癫痫大发作及部分性发作的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636551015","title":"股市必读：新华制药（000756）5月15日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636551015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636551015?lang=zh_cn&edition=full","pubTime":"2026-05-18 02:39","pubTimestamp":1779043150,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，新华制药报收于14.29元，下跌1.18%，换手率1.28%，成交量6.38万手，成交额9185.8万元。来自：新华制药OB-14项目处于临床Ⅱa期，受试者入组已完成，公司正扎实推进研发进展。机构调研要点新华制药与鲁抗医药虽同属华鲁集团旗下的医药行业上市公司，但二者不存在实质性同业竞争问题。新华制药主要产品系解热镇痛类、心脑血管类及中枢神经类等药物；鲁抗医药主要产品包括抗生素原料药、制剂产品和兽用抗生素。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635733205","title":"新华制药（000756）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635733205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635733205?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:25","pubTimestamp":1778682318,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，新华制药报收于14.66元，较前一交易日下跌0.68%，最新总市值为102.13亿元。该股当日开盘14.75元，最高14.8元，最低14.63元，成交额达1.16亿元，换手率为1.58%。近日，新华制药发布《关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告》。公告显示，公司将于2026年5月15日15:00-16:30通过网络远程方式参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的“2026年山东辖区上市公司投资者网上集体接待日活动”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635920536","title":"新华制药：公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2635920536","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635920536?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:03","pubTimestamp":1778655793,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药(000756)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问：新华制药有预防或者治疗汉坦病毒的药物吗？新华制药回复：您好，公司是布洛芬等系列解热镇痛药物全球重要供应商，公司已布局并生产阿昔洛韦、利巴韦林、奥司他韦、帕拉米韦等系列抗病毒产品及糖皮质激素系列、抗感染系列药物。具体以医生治疗方案为准。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300021629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634401641","title":"新华制药：氨溴特罗口服溶液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634401641","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634401641?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:49","pubTimestamp":1778489340,"startTime":"0","endTime":"0","summary":"南财智讯5月11日电，新华制药公告，公司收到国家药品监督管理局签发的氨溴特罗口服溶液《药品注册证书》。该产品用于治疗急、慢性呼吸道疾病（如急、慢性支气管炎、肺气肿等）引起的咳嗽、痰液黏稠、排痰困难、喘息等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733124867.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733124867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786676176708,"stockEarnings":[{"period":"1week","weight":-0.0182},{"period":"1month","weight":-0.0283},{"period":"3month","weight":-0.0072},{"period":"6month","weight":-0.0946},{"period":"1year","weight":-0.1469},{"period":"ytd","weight":-0.0793}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"1997-08-06","address":"山东省淄博市张店区高新技术产业开发区化工区","registeredCapital":"69668万元","survey":" 山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是解热镇痛类等原料药、片剂、针剂、胶囊剂等制剂、医药中间体及其他。","listedPrice":3.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}